Market Tracker

02/22 3:37am ET

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

7.79
Delayed Data
As of Feb 21
 +0.08 / +1.04%
Today’s Change
7.52
Today|||52-Week Range
12.30
-5.00%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close7.71
Today’s open7.78
Day’s range7.72 - 8.00
Volume189,759
Average volume (3 months)329,023
Market cap$306.6M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-200.25%
Earnings growth (this year)+625.00%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-13.04%
P/E ratio4.0
Price/Sales2.86
Price/Book7.54

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...+0.60+3.50%
GLYCGlycoMimetics Inc+0.34+1.41%
TLGTTeligent Inc-0.01-0.33%
DEPODepomed Inc----
Data as of 4:15pm ET, 02/21/2018

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$149.8M
Annual profit (last year)-$41.2M
Net profit margin-27.47%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Chief Financial Officer &
Senior Vice President
Michael F. Kanan
Corporate headquarters
Dublin, Dublin

Forecasts